Jan 11, 2017
With Illumina set to start shipping its newest sequencers as early as March, Dr. Richard Gibbs talks with Sharon Begley of STAT and weighs in on the potential for decreasing costs.
“Just getting that genomic data is half the work,” Gibbs remarked. “So if [the new sequencers] can speed that up by a factor of two or three, that’s a big deal.”